PATENT CLAIM ANALYSIS

Application Number: 15973569
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "210200"]

Abstract:
Series of 2-phenyl-4-methylthiazole analogues are disclosed as potential therapeutic agents for the treatment of bacterial infections, especially methicillin-resistant  Straphylococcus aureus  (MRSA) related infections. A method for the treatment of MRSA-related infections is also claimed.

Claim (Index 19):
A method for treating a patient with microbial infections, the method comprising the step of administering a therapeutically effective amount of one or more compounds of  claim 1 , together with one or more other therapeutically active compounds by the same or different mode of action, to the patient in need of relief from said infections.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15144311', '14111157', '14110391', '13388712', '14119673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7951540402754481
- 35 USC 102 Novelty (BERT): 0.553721766932974
- Combined Prediction Score: 0.7710108129412008
- Mean Citation Score: 379.947854
- Max Citation Score: 431.57492
- Similarity Product: 344.34592060302015

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test